Methadone dose

PreclinicalSmall molecule

NNational Institute on Drug Abuse (NIDA)

Methadone dose is one of 35 small molecule programs targeting Opioid Use Disorder. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Opioid Use DisorderActive, not recruiting

Opioid Use DisorderPreclinical

Active, not recruiting

Competition

Competitive Landscape

48 competitors in Opioid Use Disorder

#DrugCompanyPhaseTrials

Suboxone

IIndivior Inc.

Approved

20 2

Sovaldi

Gilead

Approved

1 3

Dolophine

HHikma Pharmaceuticals LLC

Approved

6 4

Cabenuva

Oxycontin

3 6

Dilaudid

RRhodes Pharmaceuticals, L.P.

Approved

3 7

MS Contin

HHikma Pharmaceuticals LLC

Approved

2 8

Lucemyra

BBioCorRx Pharmaceuticals Inc

Approved

2 9

Narcan

SScienture

Approved

2 10

Rayos

RRoxane Laboratories

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Opioid Use Disorder1 trial

Assessing Dose Taken in Opioid Use Disordered Patients With an Electrochemical Sensor

Unknown status·CCari Health Inc.··NCT05998876·45 enrolled

Treatment1 trial

Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management

Completed·NNational Institute on Drug Abuse (NIDA)·Phase 1·NCT00292110·140 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Methadone dose. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Methadone dose compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Methadone dose. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Institute on Drug Abuse (NIDA) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNational Institute on Drug Abuse (NIDA)

Methadone dose

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Opioid Use Disorder1 trial

Treatment1 trial

References

Drug Info

Quick Facts

Related News